Nefise nazlı Yenigül
Bursa, Turkey (Türkiye)
NCT Number: NCT07261618
Timely detection of fetal brain anomalies is critical for improving prenatal counseling and postnatal neurological outcomes. Ultrasonography is the most commonly used and effective imaging method for evaluating fetal structures; however, diagnostic accuracy can be affected by operator experience, fetal position, and image quality, leading to variability in interpretation. Artificial intelligence (AI)-based image analysis offers a new opportunity to standardize diagnostic assessment and reduce subjectivity in ultrasound interpretation.
This study aims to evaluate the diagnostic accuracy and clinical applicability of an AI-assisted model (Alyssia) designed to analyze archived 2D fetal brain ultrasound images. The model will be trained and validated to distinguish between normal and abnormal intracranial findings, focusing particularly on the lateral ventricles and other relevant brain regions. The research employs an observational, retrospective design using anonymized ultrasound data obtained during routine prenatal examinations between 18 and 24 weeks of gestation.
Expert clinicians will review and label all eligible images to establish ground truth classifications for model training and validation. A deep learning-based algorithm will be developed to automatically classify these images, and its performance will be evaluated using accuracy, sensitivity, specificity, precision, and F1-score metrics. Misclassified cases will be qualitatively analyzed to determine contributing factors such as image quality, anatomical variability, and gestational differences.
By comparing AI model outputs with expert-labeled references, the study will assess the model's ability to enhance diagnostic standardization and reduce inter-observer variability. The findings are expected to provide valuable insights into the integration of AI-based decision support systems in prenatal neurosonography. Ultimately, this research aims to support earlier and more reliable detection of fetal brain anomalies, contributing to improved prenatal care and healthier outcomes for mothers and infants.
This study is active but is not currently recruiting participants.
Notify Me18 year–45 year
Female
Observational
Bursa, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Artificial intelligence-based diagnostic tool designed to classify archived 2D fetal brain ultrasound images as normal or abnormal to detect intracranial anomalies.
Time frame: From study start to model validation (approximately 6 weeks).
The primary outcome is the diagnostic accuracy of the Alyssia artificial intelligence model in classifying archived 2D fetal brain ultrasound images as normal or abnormal. Model performance will be evaluated by comparing AI-generated classifications with expert-labeled ground truth data.
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Other
Evaluation of an Artificial Intelligence-Assisted Diagnostic Model for the Analysis of Archived 2D Fetal Brain Ultrasound Images to Improve Detection and Standardization of Intracranial Anomalies
Acronym: ALYSSIA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07369219
Artificial Intelligence, Colo-rectal Cancer
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07598929
Adherence Interventions, Artificial Intelligence
Merkez, Sivas, Turkey (Türkiye)
View Trial DetailsNCT06164002
Artificial Intelligence
Cairo, Al-Azhar University, Egypt
View Trial DetailsNCT06255808
Artificial Intelligence, Benign Breast Disease
Seoul, South Korea
View Trial Details